Nisa Investment Advisors
NVCT icon

Nisa Investment Advisors’s Nuvectis Pharma NVCT Stock Holding History

Nisa Investment Advisors’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.2K Buy
+500
New +$5.6K ﹤0.01% 2490
2024
Q4 		– Sell
-12
Closed -$75 – 3041
2024
Q3 		$75 Sell
12
-200
-94% -$1.32K ﹤0.01% 2923
2024
Q2 		$1.34K Buy
+212
New +$1.44K ﹤0.01% 2451

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Nisa Investment Advisors's NVCT Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 500 shares worth $9.2K. The stake represents ﹤0.01% of the portfolio and ranks #2490 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in NVCT as recently as Q3 2024.

Nisa Investment Advisors first reported a position in NVCT in Q2 2024 and has held it in 3 quarters since. 82 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Nisa Investment Advisors held 500 shares of Nuvectis Pharma worth $9.2K as of Q2 2026.
  • Nuvectis Pharma was a new Nisa Investment Advisors position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2490 holding.
  • Nisa Investment Advisors first reported a position in Nuvectis Pharma in Q2 2024 and has held it in 3 quarters since.
  • 82 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.